Search Results - "De, Ajita P."

Impact of Oxycodone HCl Extended-release Formulary Restrictions on Extended-release Opioid Market Share, Healthcare Resource Utilization and Costs in Commercial and Medicare Plans by Wade, Rolin L., Chen, Chi-Chang, De, Ajita P., Howard, Jaren C.

“…Background: Previous research demonstrated that utilization management (UM) such as prior authorization (PA) or non-formulary (NF) restrictions may reduce…”
Get full text

Using Real World Evidence to Describe Pulmonary Arterial Hypertension Treatment Patterns, Healthcare Resource Utilization, and Costs Associated with PDE-5 Inhibitor Monotherapy by Ruiz, George, Yeaw, Jason, Lickert, Cassandra A, De, Ajita P, Wade, Rolin L, Pruett, Janis, Drake, William

“…Pulmonary arterial hypertension (PAH) is described by proliferation of small pulmonary arteries leading to increased pulmonary vascular resistance, right…”
Get full text

Probabilistic data linkage: a case study of comparative effectiveness in COPD by Blanchette, Christopher M, Dekoven, Mitch, De, Ajita P, Roberts, Melissa

“…In this era of comparative effectiveness research, new, advanced techniques are being investigated by the research community to overcome the limitations of…”
Get full text

Two-year adherence and costs for biologic therapy for rheumatoid arthritis by Stolshek, Bradley S, Wade, Sally, Mutebi, Alex, De, Ajita P, Wade, Rolin L, Yeaw, Jason

“…To evaluate adherence to newly initiated biologic disease-modifying antirheumatic drugs (bDMARDs) in effectively treated patients with rheumatoid arthritis…”
Get full text

Evaluation of Patient Migration Patterns and Related Health Care Costs Within a National Medicare Advantage Prescription Drug Plan After Implementation of an Oxycodone HCl Extended-Release Access Restriction by Chen, Chi-Chang, De, Ajita P, Sweet, Brian, Wade, Rolin L

“…Health plans use formulary restrictions (e.g., prior authorization, step therapy, tier change, nonformulary status) in an effort to control cost and promote…”
Get full text

Estimation of Missed Statin Prescription Use in an Administrative Claims Dataset by Wade, Rolin L, Patel, Jeetvan G, Hill, Jerrold W, De, Ajita P, Harrison, David J

“…Nonadherence to statin medications is associated with increased risk of cardiovascular disease and poses a challenge to lipid management in patients who are at…”
Get full text

Association of cord blood leptin, soluble leptin receptor, insulin-like growth factor-I and insulin-like growth factor-binding protein-1 on birth indices in healthy full-term newborns by Tennekoon, Kamani H, Poopalapillai, Jayanthiny, Karunanayake, Akila G, Jayasinghe, Hasini D, Kumarasiri, Jayalath M, De S Wijesundera, Ajita P, Karunanayake, Eric H

“…Leptin and insulin-like growth factor-I (IGF-I) promote fetal growth. Their availability is modulated by soluble leptin receptor (SLR) and insulin-like growth…”
Get more information

Consequences of patient access restrictions to branded oxycodone hydrochloride extended-release tablets on healthcare utilization and costs in US health plans by Ben-Joseph, Rami, Chen, Chi-Chang, De, Ajita P, Wade, Rolin L, Shah, Dhvani

“…To evaluate the impact of increased access restrictions to branded oxycodone hydrochloride extended-release tablets (oxycodone HCl ER), on healthcare…”
Get more information

Synchronization of administrations of chemotherapy and erythropoiesis-stimulating agents and frequency of associated healthcare visits by Hill, Jerrold W., Shreay, Sanatan, McGarvey, November, De, Ajita P., Hess, Gregory P., Corey-Lisle, Patricia K.

“…Purpose The erythropoiesis-stimulating agents (ESAs), darbepoetin alfa (DA), and epoetin alfa (EA) differ with respect to dosing schedule in…”
Get full text

Nuclear medicine scientists: findings and recommendations based on a 2006 survey by Wing, Paul, Langelier, Margaret H, De, Ajita P

“…The following is a concise summary of key findings based on survey responses, including key themes covered in the questionnaire: personal demographics,…”
Get full text

Demographic and Comorbidity Characteristics of Newly Diagnosed Multiple Myeloma Patients in the United States: A Real World Data Analysis by Chen, Yaozhu J, De, Ajita P, Cong, Ze, Aggarwal, Sanjay K, Wade, Rolin L

“…Background Multiple myeloma (MM) remains an incurable plasma cell neoplasm with >20,000 new cases diagnosed annually in the United States (US). The…”
Get full text